Eight Advisory supported SERB Pharmaceuticals and Charterhouse Capital Partners on their acquisition of RSDL®

Eight Advisory and Eight Advisory Avocats provided financial and tax due diligence services to SERB Pharmaceuticals and its majority shareholder Charterhouse Capital Partners in the context of their acquisition of RSDL® (Reactive Skin Decontamination Lotion).
Eight Advisory team members supporting on this transaction:
- Financial due diligence: Gennat Mouline (Partner), Julien Roux (Director) and Jean-Baptiste Juszezak (Manager)
Eight Advisory Avocats team members supporting on this transaction:
- Tax due diligence: Guillaume Rembry (Partner-Attorney at law), Guillaume Exerjean (Attorney at law) and Lucie Goeller (Attorney at law)